Coloplast A/S (XSWX:COLOB)
CHF 115 0 (0%) Market Cap: 22.64 Bil Enterprise Value: 25.50 Bil PE Ratio: 40.61 PB Ratio: 11.45 GF Score: 92/100

Q4 2023 Coloplast A/S Earnings Call Transcript

Nov 09, 2023 / 10:00AM GMT
Operator

Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Coloplast Full Year 2022-2023 Earnings Release Conference Call. (Operator Instructions)

I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Thank you, operator. Good morning, and welcome to our full year '22-'23 conference call. I'm Kristian Villumsen, the CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We will start with a short presentation by Anders and myself and then open up for questions as we usually do. Could I ask you all to please turn to Slide #3.

We delivered 8% organic growth and a reported EBIT margin before special items of 28% for the '22-'23 financial year. Return on invested capital after tax and before special items was 17%, reflecting impact from the Atos Medical and Kerecis acquisitions. Now fourth quarter, we delivered organic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot